20
Nectar Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CEFTAZIDIME FOR INJECTION USP (STERILE BULK), with a corresponding US DMF Number 26469.
Remarkably, this DMF maintains an Active status since its submission on November 16, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 24, 2015, and payment made on June 11, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II